Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China.
Shanghai Research Institute of Acupuncture and Meridian, Shanghai University of Traditional Chinese Medicine, Shanghai, 200030, China.
Trials. 2018 Jan 19;19(1):52. doi: 10.1186/s13063-018-2458-1.
Vascular cognitive impairment with no dementia (VCIND), manifested mainly as mild impairment of concentration and executive function, is the early phase of vascular dementia (VD). Currently, there is no specific treatment for VCIND. We hypothesize that electrical acupuncture can improve the mental and motor functions of patients with VCIND. Thus, we designed this randomized controlled trial to test this hypothesis by comparing the therapeutic effect of electrical acupuncture versus sham acupuncture in patients with VCIND.
METHOD/DESIGN: In this single-center 3-year study, 120 eligible patients will be recruited and randomly assigned to receive electrical acupuncture treatment (n = 60) or sham acupuncture (n = 60) for 8 consecutive weeks (24 sessions in total), with the same acupoint prescription (DU20, EX-HN3, DU24, DU17, DU26, EX-HN1, HT7, PC6, GB20, SP6). The primary assessment is the Montreal Cognitive Assessment. The secondary assessments are the Modified Barthel Index and Event-Related Potential. All outcomes will be assessed at baseline, endpoint, and follow-up at 8 and 24 weeks after the end of treatment.
If the outcome confirms the effectiveness and safety of electrical acupuncture in treating VCIND, this treatment is expected to be promoted in clinical practice to treat such patients.
Chinese Clinical Trial Registry identifier: ChiCTR-IIR-17011513 ; Registered on 27 May 2017.
血管性认知障碍但无痴呆(VCIND),主要表现为注意力和执行功能轻度受损,是血管性痴呆(VD)的早期阶段。目前,VCIND 尚无特异性治疗方法。我们假设电针可能改善 VCIND 患者的精神和运动功能。因此,我们设计了这项随机对照试验,通过比较电针与假针刺治疗 VCIND 患者的疗效来检验这一假设。
方法/设计:在这项为期 3 年的单中心研究中,将招募 120 名符合条件的患者,并随机分为电针治疗组(n = 60)或假针刺组(n = 60),接受连续 8 周(共 24 次)的治疗,采用相同的穴位处方(DU20、EX-HN3、DU24、DU17、DU26、EX-HN1、HT7、PC6、GB20、SP6)。主要评估指标为蒙特利尔认知评估。次要评估指标为改良巴氏指数和事件相关电位。所有结局均在基线、终点以及治疗结束后 8 周和 24 周进行评估。
如果结果证实电针治疗 VCIND 的有效性和安全性,预计该治疗方法将在临床实践中推广,用于治疗此类患者。
中国临床试验注册中心标识符:ChiCTR-IIR-17011513;注册于 2017 年 5 月 27 日。